News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|November 14, 2021

Inside AAGL 2021: The future of MIGS: globalization and innovation

Author(s)Lindsey Carr, Editor

Hear from Mauricio S. Abrão, MD, PhD, 2021 scientific program chair and upcoming president of AAGL, and Executive Director Linda Michels, discuss key topics and critical updates at AAGL 2021 you don’t want to miss.

Contemporary OB/GYN® is live in Austin this week at the American Association of Gynecologic Laparoscopists’ (AAGL) 50th Annual Congress on Minimally Invasive Gynecologic Surgery (MIGS). Follow along for the latest coverage.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Oral zoliflodacin offers new option for gonorrhea treatment, says Edward Hook, MD

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

ByEdward Hook, MD

December 12th 2025

FDA approves Nuzolvence (zoliflodacin) for uncomplicated gonorrhea

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

ByMorgan Ebert, Managing Editor

December 12th 2025

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more

ByCeleste Krewson, Assistant Editor

December 12th 2025

George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia

George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia

ByGeorge L. Maxwell, MD

December 12th 2025

Zoliflodacin demonstrated non-inferiority in adults and adolescents with gonorrhea | Image Credit: ©Giovanni Cancemi - stock.adobe.com.

Zoliflodacin demonstrated non-inferiority in adults and adolescents with gonorrhea

ByMorgan Ebert, Managing Editor

December 11th 2025

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more

© 2025 MJH Life Sciences^®

All rights reserved.